A universal co-expression gene network and prognostic model for hepatic-biliary-pancreatic cancers identified by integrative analyses

被引:6
作者
Zhang, Jing [1 ]
Xiao, Juan [2 ]
Wang, Yixuan [1 ]
Zheng, Xiao [1 ]
Cui, Jiajun [1 ]
Wang, Chaochen [1 ]
机构
[1] Zhejiang Univ, Sch Med, Zhejiang Univ Univ Edinburgh Inst ZJU UoE Inst, Int Campus, Haining 314400, Zhejiang, Peoples R China
[2] Guilin Med Univ, Affiliated Hosp, Guangxi Key Lab Mol Med Liver Injury & Repair, Guilin, Peoples R China
关键词
cholangiocarcinoma; hepatocellular carcinoma; pancreatic adenocarcinoma; prognosis; training cohort; validation cohort; LUNG-CANCER; BIOMARKERS;
D O I
10.1002/2211-5463.13478
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatic, biliary and pancreatic cancers are a diverse set of malignancies with poor prognoses. It is possible that common molecular mechanisms are involved in the carcinogenesis of these cancers. Here, we identified LINC01537 and seven protein-coding genes by integrative analysis of transcriptomes of mRNAs, microRNAs and long non-coding RNAs from cholangiocarcinoma, hepatocellular carcinoma and pancreatic adenocarcinoma cohorts in TCGA. A predictive model constructed from seven biomarkers was established to successfully predict the survival rate of patients, which was then further verified in external cohorts. Additionally, patients with high-risk scores in our model were prone to epithelial-mesenchymal transition. Finally, activation of the biomarker PDE2A significantly attenuated migration and epithelial-mesenchymal transition in the HepG2 liver cancer cell line.
引用
收藏
页码:2006 / 2024
页数:19
相关论文
共 58 条
[1]   Pancreatic cancer: yesterday, today and tomorrow [J].
Ansari, Daniel ;
Tingstedt, Bobby ;
Andersson, Bodil ;
Holmquist, Fredrik ;
Sturesson, Christian ;
Williamsson, Caroline ;
Sasor, Agata ;
Borg, David ;
Bauden, Monika ;
Andersson, Roland .
FUTURE ONCOLOGY, 2016, 12 (16) :1929-1946
[2]  
BEVILACQUA M, 1991, CANCER, V67, P2543, DOI 10.1002/1097-0142(19910515)67:10<2543::AID-CNCR2820671026>3.0.CO
[3]  
2-L
[4]   Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma [J].
Chen, Dung-Tsa ;
Davis-Yadley, Ashley H. ;
Huang, Po-Yu ;
Husain, Kazim ;
Centeno, Barbara A. ;
Permuth-Wey, Jennifer ;
Pimiento, Jose M. ;
Malafa, Mokenge .
PLOS ONE, 2015, 10 (08)
[5]   Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma [J].
Chen, Guoqiao ;
Fan, Xiaoxiao ;
Li, Yirun ;
He, Lifeng ;
Wang, Shanjuan ;
Dai, Yili ;
Bin, Cui ;
Zhou, Daizhan ;
Lin, Hui .
EPIGENETICS, 2020, 15 (6-7) :684-701
[6]   Generation of Inducible CRISPRi and CRISPRa Human Stromal/Stem Cell Lines for Controlled Target Gene Transcription during Lineage Differentiation [J].
Chen, Li ;
Shi, Kaikai ;
Qiu, Weimin ;
Aagaard, Lars ;
Kassem, Moustapha .
STEM CELLS INTERNATIONAL, 2020, 2020
[7]   Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors [J].
Collins, I ;
Garrett, MD .
CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (04) :366-373
[8]   Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation [J].
Dannenberg, Luke O. ;
Edenberg, Howard J. .
BMC GENOMICS, 2006, 7 (1)
[9]  
Deng Z., 2019, BIOMED RES INT, V2019, P1
[10]   Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma [J].
Fan, Jing ;
Li, Jiayan ;
Han, Jianbo ;
Zhang, Yufeng ;
Gu, Aidong ;
Song, Fangnan ;
Duan, Jie ;
Yin, Dandan ;
Wang, Lili ;
Yi, Yongxiang .
MOLECULAR IMMUNOLOGY, 2021, 136 :82-97